Pour les femmes
DERMESTRIL 25 transdermale Pflaster 24 St (Estradiol 2 mg), DERMESTRIL 25 patchs transdermiques
DERMESTRIL-Septem 25 Mikrogramm/24 Std transdermale Pflaster 12 Stk.(Estradiol 2,5 mg), DERMESTRIL-Septem 25 microgrammes/24 heures dispositifs transdermiques
DERMESTRIL-Septem 50 Mikrogramm/24 Std transdermale Pflaster 12 Stk.(Estradiol 5 mg), DERMESTRIL-Septem 50 microgrammes/24 heures dispositifs transdermiques
DERMESTRIL-Septem 75 Mikrogramm/24 Std
Special care is required when using DERMESTRIL-Septem:
Talk to your doctor before starting treatment if you have ever had any of the following problems, as they may recur or worsen during treatment with DERMESTRIL-Septem. If this happens, you should see your doctor more often for check-ups:
- Uterine fibrosis
- Growth of uterine lining outside the uterus (endometriosis) or history of excessive growth of the uterine lining (endometrial hyperplasia)
- increased risk of developing blood clots (see “Blood clots in a vein (thrombosis)”)
- increased risk of developing estrogen-sensitive cancer (such as a mother, sister, or grandmother who had breast cancer)
- high blood pressure
- Liver disease, e.g. benign liver tumor
- diabetes
- Gallstones
- Migraine or severe headache
- Disease of the immune system that affects many organs of the body (systemic lupus erythematosus, SLE )
- epilepsy
- asthma
- Disease that affects the eardrum and hearing (otosclerosis)
- very high blood lipid levels (triglycerides)
- Fluid accumulation due to heart and kidney problems
- congenital or acquired angioedema.
-
Skin irritation at application site
-
Breast tenderness
-
Headache, nausea, or vaginal bleeding
